Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
6.31
+0.39 (6.59%)
At close: Jan 13, 2026, 4:00 PM EST
6.36
+0.05 (0.79%)
After-hours: Jan 13, 2026, 7:37 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Antibody-based Therapies
74.21M
Log In
Log In
Log In
Log In
Upgrade
Antibody-based Therapies Growth
-13.90%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States
74.21M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-13.90%
Log In
Log In
Log In
Log In
Upgrade